O-GlcNAc Signaling Entrains the Circadian Clock by Inhibiting BMAL1/CLOCK Ubiquitination  by Li, Min-Dian et al.
Cell Metabolism
Short ArticleO-GlcNAc Signaling Entrains the Circadian Clock
by Inhibiting BMAL1/CLOCK Ubiquitination
Min-Dian Li,1,2 Hai-Bin Ruan,1,2 Michael E. Hughes,1,3 Jeong-Sang Lee,1,2 Jay P. Singh,1,2 Steven P. Jones,4
Michael N. Nitabach,1,3 and Xiaoyong Yang1,2,*
1Department of Cellular and Molecular Physiology
2Section of Comparative Medicine, Program in Integrative Cell Signaling and Neurobiology of Metabolism
3Department of Genetics, Program in Cellular Neuroscience, Neurodegeneration and Repair
Yale University School of Medicine, New Haven, CT 06520, USA
4Department of Medicine, Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40202, USA
*Correspondence: xiaoyong.yang@yale.edu
http://dx.doi.org/10.1016/j.cmet.2012.12.015SUMMARY
Circadian clocks are coupled to metabolic oscilla-
tions through nutrient-sensing pathways. Nutrient
flux into the hexosamine biosynthesis pathway trig-
gers covalent protein modification by O-linked b-D-
N-acetylglucosamine (O-GlcNAc). Here we show
that the hexosamine/O-GlcNAc pathway modulates
peripheral clock oscillation. O-GlcNAc transferase
(OGT) promotes expression of BMAL1/CLOCK
target genes and affects circadian oscillation of
clock genes in vitro and in vivo. Both BMAL1 and
CLOCK are rhythmically O-GlcNAcylated, and this
protein modification stabilizes BMAL1 and CLOCK
by inhibiting their ubiquitination. In vivo analysis of
genetically modified mice with perturbed hepatic
OGT expression shows aberrant circadian rhythms
of glucose homeostasis. These results establish the
counteraction between O-GlcNAcylation and ubiqui-
tination as a key mechanism that regulates the circa-
dian clock and suggest a crucial role for O-GlcNAc
signaling in transducing nutritional signals to the
core circadian timing machinery.
INTRODUCTION
Almost all mammalian cells contain a self-sustained circadian
(about 24 hr) clock that runs in tight synchrony with environ-
mental cues including light and food (Bass and Takahashi,
2010). While the master pacemaker residing in the hypothalamic
suprachiasmatic nucleus (SCN) is entrained directly by light,
peripheral circadian oscillators can be entrained by diurnal
feeding (Schibler and Sassone-Corsi, 2002). Among various
macronutrients, glucose is a particularly potent entraining cue
for peripheral clocks (Stephan and Davidson, 1998). Cellular
nutrient sensors such as nuclear receptors have been proposed
as mechanisms for entrainment by food (Asher and Schibler,
2011; Yang, 2010; Yang et al., 2006), but the molecular basis
for glucose-mediated entrainment remains a mystery.
Circadian timekeeping occurs at the cellular level by virtue
of transcriptional-translational autoregulatory feedback loopsCell M(Mohawk et al., 2012). The transcriptional activators BMAL1
and CLOCK drive expression of Period (Per1 and Per2) and
Cryptochrome (Cry1 and Cry2) genes. PER and CRY proteins
accumulate progressively and in turn inhibit BMAL1/CLOCK
activity, thus generating the approximate 24 hr cycle of clock
gene expression. The pace of oscillation of this autofeedback
loop is controlled by various regulatory mechanisms including
posttranslational modifications of clock proteins (Bass and
Takahashi, 2010).
Cells possess a distinct form of posttranslational modifi-
cation that is highly sensitive to nutrient availability. Glucose
flux via the hexosamine biosynthesis pathway leads to intracel-
lular glycosylation by addition of b-D-N-acetylglucosamine
(GlcNAc) to many cytoplasmic and nuclear proteins at the
hydroxyl groups of serine and threonine residues (Hanover
et al., 2012; Hart et al., 2011). This widespread and dynamic
glycosylation is mediated by O-linked GlcNAc transferase
(OGT) and O-GlcNAcase (OGA), which catalyze sugar addi-
tion and removal, respectively. O-GlcNAc modification is
increasingly recognized as a key regulator of diverse cellular
processes. O-GlcNAcylation of a number of transcription
factors mediates the effects of glucose on transcription of
genes involved in key metabolic processes (Hart et al., 2011).
A recent study has shown that O-GlcNAcylation links the
cardiomyocyte circadian clock to metabolic outputs (Durgan
et al., 2011). In Drosophila, O-GlcNAcylation of the PER
protein has been shown to contribute to setting the clock
speed (Kim et al., 2012). The present study provides direct
evidence that glucose availability regulates cellular clock oscil-
lation through the hexosamine/O-GlcNAc pathway. We further
demonstrate that BMAL1 and CLOCK are key targets of
O-GlcNAcylation, and this modification inhibits ubiquitination
and degradation of these proteins. Accordingly, this work
establishes a new mechanism for metabolic entrainment of
the circadian clock by covalent modification of core clock
components.RESULTS
The Hexosamine/O-GlcNAc PathwayModulates Cellular
Clock Oscillation
In light of the important role of food-derived signals for peripheral
clock entrainment, we examined whether the nutrient-sensingetabolism 17, 303–310, February 5, 2013 ª2013 Elsevier Inc. 303
Figure 1. The Hexosamine/O-GlcNAc Pathway Modulates Cellular Clock Oscillation
(A) Average real-time bioluminescence from synchronized U2OS-B6 cells stably expressing aBmal1-luciferase construct in the presence or absence of azaserine
(n = 5). The vertical bar represents relative luminescence (Rel. Lum.). Circadian parameters were calculated by JTK_CYCLE.
(B) qRT-PCR analysis of synchronized U2OS-B6 cells (n = 3; 5G/25G, 5/25 mM glucose; AZA, azaserine).
(C) Immunoblot analysis of synchronized U2OS-B6 cells (n = 3 per lane).
(D) qRT-PCR analysis of synchronized U2OS-B6 cells transfected with GFAT1 siRNA (n = 3).
(E) qRT-PCR analysis of OGT knockdown on clock oscillation in synchronized U2OS-B6 cells (n = 3).
(F) Average real-time bioluminescence of OGT knockdown on clock oscillation in synchronized U2OS-B6 cells (n = 5). siCTL, scrambled siRNA; siGFAT1,
GFAT1 siRNA; siOGT, OGT siRNA. All data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by ANOVA with Bonferroni’s post hoc
test or two-tailed Student’s t test.
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methasone synchronization, U2OS cells (U2OS-B6) stably
expressing a Bmal1-luciferase reporter construct were grown
in high (25 mM) glucose culture medium containing D-luciferin
and monitored by the real-time bioluminescence recording
system. Addition of azaserine, an inhibitor of hexosamine
biosynthesis (Figure S1A), increases the period length and
decreases the amplitude of Bmal1 oscillation (Figure 1A). D-
glucosamine is able to fuel the cellular pool of UDP-GlcNAc,
the donor substrate of O-GlcNAcylation (Figure S1A). Addition
of D-glucosamine dramatically delays the phase of Bmal1
oscillation (Figure S1B). These data indicate a role for the
hexosamine pathway in circadian regulation.
To substantiate our observations, we examined the oscillation
of endogenous clock genes in synchronized U2OS-B6 cells.
Compared with low (5 mM) glucose, high glucose increases
the amplitude of Bmal1 and Cry1 messenger RNA (mRNA)
oscillation, whereas azaserine suppresses them (Figure 1B).304 Cell Metabolism 17, 303–310, February 5, 2013 ª2013 Elsevier InImmunoblot analysis shows that low glucose and azaserine
also decrease BMAL1 protein levels as compared with high
glucose (Figure 1C). Although the glucose concentrations do
not affect the phase of Bmal1 mRNA cycling (Figure 1B), low
glucose delays the phase of BMAL1 protein accumulation
(Figure 1C), suggesting that glucose can regulate BMAL1 levels
posttranscriptionally.
GFAT1 is the first and rate-limiting enzyme in hexosamine
biosynthesis and the target of azaserine. The small interfering
RNA (siRNA)-mediated knockdown of GFAT1 decreases
expression of Bmal1 and Cry1 (Figures 1D and S1C), which is
also seen in the cells transfected with OGT siRNA (Figures 1E
and S1D). Consistently, OGT knockdown reduces BMAL1
protein abundance (Figure S1E). Furthermore, OGT knockdown
dramatically decreases the amplitude of the Bmal1-luciferase
rhythm (Figure 1F). Taken together, these data demonstrate
that the hexosamine/O-GlcNAc pathway regulates cellular
clock oscillation.c.
Figure 2. OGT Promotes Expression of
BMAL1/CLOCK Target Genes
(A) Diurnal levels ofGfat1 andOgtmRNA in mouse
livers (n = 4). Data were normalized to that of
u36b4.
(B) qRT-PCR analysis of U2OS cells infected with
the adenovirus expressing OGT (n = 3).
(C) qRT-PCR analysis of OGTflox/Y mouse primary
hepatocytes transduced with the adenoviral
vector expressing Cre recombinase (n = 3).
(D) Per2-luciferase assays of HeLa cells transiently
expressing OGT, Myc-BMAL1, and Myc-CLOCK
constructs (n = 3). GFP was used to equalize the
total plasmid amount. Luminescence signals were
normalized to that of GFP control groups. Immu-
noblot analysis of cell lysates is shown to confirm
overexpression of OGT.
(E) Chromatin immunoprecipitation (ChIP)-qPCR
analysis of mouse primary hepatocytes using an
O-GlcNAc antibody (n = 3). ChIP with mouse IgG
was used as the negative control. The diagram of
assayed DNA regions is shown on the right. qPCR
signals were normalized to those from genomic
DNA inputs. All data are shown as mean ± SEM.
*p < 0.05, **p < 0.01, ***p < 0.001; two-tailed
Student’s t test.
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Genes
To further dissect the circadian function of hexosamine
signaling, we examined the rhythmicity of expression of key
genes in this pathway. In mouse livers, diurnal levels of Gfat1
transcripts are ultradian with a 12 hr period, whereas Ogt
transcripts oscillate in a circadian manner (Figure 2A). Oga
expression exhibits a weak diurnal rhythm (Figure S2A).
To investigate whether rhythmic hexosamine signaling affects
expression of clock genes, we analyzed endogenous gene
expression in U2OS cells transiently expressing GFP or OGT
from recombinant adenovirus vectors. The results show that
OGT significantly increases expression of Per2 and Cry1 (Fig-
ure 2B). In contrast, Cre-induced homologous recombina-
tion in OGTflox/Y mouse primary hepatocytes that eliminates
OGT expression decreases expression of BMAL1/CLOCK
target genes, including Per1, Per2, Cry1, and Rorc genes
(Figure 2C). Luciferase reporter assays using a Per2-luciferase
construct reveal that OGT promotes BMAL1/CLOCK-mediated
activation of Per2 transcription, whereas the catalytically dead
OGTE899A/E900A (OGTEE/AA) has no effect (Figures 2D, S2B, and
S2C). These results indicate that OGT increases BMAL1/CLOCK
transcriptional activity by an enzymatic mechanism and thereby
promotes expression of BMAL1/CLOCK target genes.
Rhythmic O-GlcNAcylation Stabilizes BMAL1
and CLOCK by Inhibiting Their Ubiquitination
The circadian Dbp gene contains the conserved E-box motifs
recognized by BMAL1/CLOCK (Ripperger and Schibler, 2006).
Chromatin immunoprecipitation using an anti-O-GlcNAc anti-
body reveals that O-GlcNAcylated proteins associate with the
Dbp E-box region (Figure 2E). This suggests that the BMAL1/
CLOCK complex itself could be O-GlcNAcylated. To test this
possibility, we immunoprecipitated epitope-tagged BMAL1
and CLOCK proteins expressed in synchronized U2OS cellsCell Mand assayed the O-GlcNAc levels of BMAL1 and CLOCK over
a complete circadian cycle. Immunoblot analysis reveals that
both BMAL1 and CLOCK are O-GlcNAcylated rhythmically
(Figure 3A). O-GlcNAcylation of endogenous CLOCK proteins
is decreased by azaserine treatment (Figure S3A), support-
ing the importance of the hexosamine pathway in circadian
regulation.
It has been known that OGT can modulate protein stability
(Dey et al., 2012; Ruan et al., 2012). Whether OGT regulates
CLOCK stability was tested by treating HEK293T cells express-
ing Myc-tagged CLOCK in the presence or absence of exoge-
nous OGT with cycloheximide (Figure 3B). OGT overexpression
increases the estimated half-life of CLOCK proteins. In line
with this, we found that OGT overexpression decreases the
steady-state ubiquitination of CLOCK (Figure 3C).
As shown in Figure 3A, BMAL1 is also O-GlcNAcylated. The
Database of O-GlcNAcylated Proteins and Sites (dbOGAP)
predicts S418 in mouse BMAL1 as a putative modification site
(Wang et al., 2011) (Figure S3B). Mutation of S418 to alanine
(S418A) decreases, but does not abolish, O-GlcNAcylation of
BMAL1 (Figure 3D). To investigate whether O-GlcNAc modifica-
tion on BMAL1 regulates its stability, Myc-tagged wild-type (WT)
BMAL1 or S418A mutant was transiently expressed in HEK293T
cells in the presence or absence of exogenous OGT and treated
with cycloheximide (Figure 3E). The BMAL1 S418A mutant
degrades faster than the WT protein, and OGT overexpression
increases the half-life of BMAL1, as it does on CLOCK (Figures
3B and 3E). To test whether O-GlcNAcylation regulates BMAL1
stability by inhibiting ubiquitination, HEK293T cells transiently
expressing Myc-tagged BMAL1 WT or S418A were treated
with the proteasome inhibitor MG132 in the presence or absence
of the OGA inhibitor PUGNAc. Elevation of global O-GlcNAc
levels by PUGNAc leads to decreased ubiquitination, and
BMAL1S418A hasmore attached ubiquitins thanWT (Figure 3F).
Per2-luciferase reporter assays show that BMAL1 S418Aetabolism 17, 303–310, February 5, 2013 ª2013 Elsevier Inc. 305
Figure 3. O-GlcNAcylation Stabilizes CLOCK and BMAL1 by Inhibiting Ubiquitination
(A) CircadianO-GlcNAc levels of BMAL1/CLOCK in synchronized U2OS cells transiently expressing Myc-tagged BMAL1 or CLOCK.O-GlcNAc levels normalized
to levels of BMAL1 and CLOCK proteins are shown below the BMAL1 blot.
(B–C) HEK293T cells were transfected with Myc-CLOCK in the absence or presence of Flag/HA (FH)-tagged OGT. (B) Immunoblot analysis of CLOCK upon
cycloheximide (CHX) treatment. Half-lives of Clock are shown. (C) Immunoblot analysis of ubiquitination of CLOCK. Cells were pretreated with MG132 and
subjected to immunoprecipitation.
(D) HEK293T cells were transfected with Myc-taggedWT or S418A mutant BMAL1.O-GlcNAcylation of BMAL1 was determined when pretreated with or without
PUGNAc.
(E) Stability of WT and S418A BMAL1 in the absence or presence of FH-OGT was determined by CHX treatment of transfected HEK293T cells.
(F) Immunoblot analysis of ubiquitination of BMAL1 WT and S418A in HEK293T cells. Cells were pretreated with MG132 and subjected to immunoprecipitation.
(G) Immunoblot analysis of Myc-tagged BMAL1/CLOCK upon CHX treatment in the presence or absence of Flag-BAP1.
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coexpressed with CLOCK (Figure S3C).
The nuclear deubiquitinase BRCA1-associated protein 1
(BAP1) has recently been characterized as an OGT-binding
protein that removes the ubiquitin markers on other associated
proteins (Dey et al., 2012; Ruan et al., 2012). It follows that306 Cell Metabolism 17, 303–310, February 5, 2013 ª2013 Elsevier InOGT-targeted proteins are likely to be regulated by BAP1. Coex-
pression of BAP1 in HEK293T cells transiently expressing Myc-
tagged BMAL1 or CLOCK reveals that BAP1 stabilizes both
proteins (Figure 3G). Based on these results, we conclude that
OGT stabilizes BMAL1 and CLOCK through directO-GlcNAcyla-
tion, which prevents ubiquitination and subsequent degradation.c.
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Rhythm of Glucose Homeostasis
In line with the results from U2OS cells (Figure 1C), immunopre-
cipitation analysis ofO-GlcNAcylated proteins frommouse livers
shows diurnal variations in O-GlcNAcylation of BMAL1 and
CLOCK that peak in the fed/dark phase (Figure 4A). Consistently,
O-GlcNAcylation of hepatic BMAL1/CLOCK is increased by re-
feeding, confirming that O-GlcNAcylation of clock proteins is
responsive to food availability (Figure S4A). To determine
whether O-GlcNAcylation regulates circadian clocks in vivo,
we generated liver-specific OGT overexpression mice by tail-
vein injection of recombinant adenovirus (Figure 4B). Analysis
of circadian transcripts in livers of these mice shows that OGT
overexpression advances the phase of Bmal1 and Clock and
increases expression levels of Per2, Cry1, Rorg, and Dbp during
the peak phase (Figures 4B and S4B and Table S1), supporting
the notion that O-GlcNAcylation increases BMAL1/CLOCK-
mediated E-box-dependent transcription.
To study the effects of O-GlcNAc deficiency on clock oscilla-
tion, we generated liver-specific OGT knockout mice by tail-
vein injection of the recombinant adenovirus expressing Cre
recombinase into OGT-floxed mice. Immunoblot analysis
shows that BMAL1 and CLOCK exhibit decreased O-GlcNAc
levels in mouse livers (Figure S4C). The oscillation of Bmal1
transcripts exhibits decreased amplitude due to reduced peak
levels (Figure 4C). However, Per2 and Cry1 oscillation is
unchanged (Figure S4D), suggesting the existence of com-
pensatory mechanisms. Together, these results indicate that
O-GlcNAcylation regulates circadian rhythms of clock gene
expression in vivo.
Nutrient-dependent peripheral clock entrainment allows
metabolic tissues to optimize the timing of their metabolic
processes. Accordingly, we examined whether glucose-respon-
sive O-GlcNAc signaling in the liver affects diurnal rhythms of
glucose metabolism. The results show that overexpression of
OGT boosts the diurnal rhythm of blood glucose, whereas
control mice maintain a weak diurnal variation of circulating
glucose (Figure 4D). Knockout of OGT advances the circulating
glucose rhythm by 6–8 hr and induces hyperglycemia in the
daytime (Figure 4E). To assess the circadian metabolic effects
of reduced O-GlcNAc signaling, we assayed the circadian
responses of OGT deficient animals to intraperitoneal injection
of a bolus of glucose. While control mice exhibit diurnal changes
in glucose tolerance, depletion of OGT exacerbates the already
poor glucose tolerance at ZT1 (1 hr into the light phase), which is
not seen at ZT13 (Figure 4F). Gluconeogenesis is known to be
circadian. qRT-PCR analysis of liver transcripts shows that
rhythmic expression of gluconeogenic genes is perturbed
by OGT overexpression or depletion (Figures S4B and S4D).
This indicates that O-GlcNAc signaling is important for diurnal
regulation of glucose metabolism in vivo and supports the
conclusion that OGT acts as a nutrient-sensing mediator that
resets peripheral circadian clocks.
DISCUSSION
Here we have shown that the hexosamine/O-GlcNAc pathway
regulates the circadian clock in peripheral tissues. It has
been known for a decade that diurnal variation in nutrientCell Mavailability can override the light/dark cycle to entrain circadian
rhythms in peripheral tissues (Damiola et al., 2000; Stokkan
et al., 2001). How metabolic signals entrain the circadian
clock remains a central question in circadian biology (Bass
and Takahashi, 2010). Among macronutrients, glucose has
a prominent role in metabolic entrainment (Hirota et al., 2002;
Stephan and Davidson, 1998). Extracellular glucose levels
modulate intracellular UDP-GlcNAc and subsequent O-GlcNAc
levels through the hexosamine biosynthesis pathway (Fig-
ure S1A). OGT overexpression increases the amplitude of
clock oscillation in vivo (Figure 4B), whereas OGT knockout
decreases O-GlcNAcylation and protein abundance of BMAL1
and CLOCK as well as Bmal1 oscillation (Figures 4C and
S4B). Notably, depletion of OGT in liver fails to perturb
oscillation of the core oscillator genes Per and Cry (Figure S4D).
This conundrum may be explained by the dominant effect
of cryptic oscillating systemic cues (Hughes et al., 2012;
Kornmann et al., 2007). For instance, Hughes et al. (2012) found
that recovery of the SCN clock in clock mutant mice is
sufficient to reestablish the circadian rhythm of the liver clock.
Whether O-GlcNAc signaling is integral to food entrainment
in peripheral clocks is an important subject for further
investigation.
We further demonstrate that O-GlcNAcylation on BMAL1
and CLOCK prevents their protein degradation by inhibiting
ubiquitination. The control of BMAL1/CLOCK protein stability
is emerging as a critical layer of regulation on the amplitude
and phase of clock oscillation (Cardone et al., 2005; Lee et al.,
2008; Sahar et al., 2010; Stratmann et al., 2012). We have
demonstrated that O-GlcNAcylation stabilizes BMAL1/CLOCK
and thereby increases BMAL1/CLOCK-mediated transcription
of genes in the negative limb of the clock such as Per and Cry
(Figures 3 and 4). O-GlcNAcylation of PER and other compo-
nents could further stabilize the negative limb (Kim et al.,
2012). Together, our study helps establish a framework for
understanding the crosstalk between different protein modifica-
tions on the positive limb of the circadian clock and provide
a potential mechanism for food entrainment.
In the physiological context, perturbation of O-GlcNAc
signaling in liver affects the diurnal rhythm of glucose homeo-
stasis (Figures 4D–4F). OGT has been established as
a suppressor of insulin signaling and a mediator of glucocorti-
coid transrepression and gluconeogenesis (Dentin et al., 2008;
Housley et al., 2009; Li et al., 2012; Ruan et al., 2012; Yang
et al., 2008). Thus, changes in plasma glucose rhythm are likely
due to the combined effects of OGT on the circadian clock and
nutrient/hormone signaling.
In summary, the present study establishes the crosstalk
between O-GlcNAcylation and ubiquitination as a key molec-
ular mechanism underlying metabolic entrainment of the
circadian clock, supporting the concept that various post-
translational modifications on the clock proteins integrate
environmental and physiological cues to control circadian
rhythms. Diurnal rhythms of O-GlcNAc signaling have broad
implications for the circadian regulation of physiological
processes in peripheral tissues, and the O-GlcNAc cycling
enzymes OGT and OGA are thus potential drug targets for
treating disorders at the interface of nutrient metabolism and
circadian rhythms.etabolism 17, 303–310, February 5, 2013 ª2013 Elsevier Inc. 307
Figure 4. OGT Regulates Expression of Clock Genes and Glucose Homeostasis in Mouse Livers
(A) Diurnal O-GlcNAc profiles of BMAL1/CLOCK in mouse livers (n = 3 per time point). Results of densitometry analysis are shown on the right.
(B) Diurnal gene expression profiles of male mouse livers transduced with Ad-OGT (n = 4 per time point). Data were normalized to u36b4.
(C) Diurnal gene expression profiles of Ogt-floxed female mouse livers transduced with Ad-Cre (n = 3 per time point). Data were normalized to Gapdh.
(D) Diurnal plasma glucose levels in male mice overexpressing OGT in livers (n = 7).
(E) Diurnal plasma glucose levels in female OGTflox/flox mice overexpressing Cre in livers (n = 12).
(F) Diurnal plasma glucose responses to intraperitoneal glucose tolerance tests (GTT) at week 12 in male mice expressing scrambled shRNA (shCTL) or OGT
shRNA (shOGT) in the liver (n = 7). Average areas under curve (AUC) of GTT curves are shown on the right. All data are shown asmean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001; ANOVA with Bonferroni’s multiple comparison test.
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Cell Culture
U2OS, HeLa, and HEK293T cells were maintained in high glucose Dulbecco’s
modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS). U2OS-
B6 cells were maintained in high glucose DMEM with 2 mg/ml of Puromycin
(Sigma-Aldrich) and 10% FBS. Primary hepatocytes were isolated by Yale
Liver Center Core Facility and plated in DMEM with 10% FBS, 2 mM sodium
pyruvate, 1 mM dexamethasome, and 0.1 mM insulin on Collagen I coated
plates. U2OS-B6 cells were transfected by Lipofectamine 2000 (Invitrogen).
U2OS, HeLa, and HEK293T cells were transfected with FuGENE HD (Prom-
ega). For time course studies of BMAL1/CLOCK O-GlcNAc modification,
U2OS cells were transfected upon confluence, cultured for 2 days, then
shocked by 100 nM dexamethasone for 90 min and switched to fresh high
glucose DMEM with 10% FBS. For expression assays, primary hepatocytes
and U2OS cells were infected with adenoviruses in serum-free DMEM con-
taining 0.5% BSA. Azaserine (20 mM), D-glucosamine (5 mM), PUGNAc
(10 mM, 16 hr), MG132 (20 mM, 4 hr), and Cycloheximide (100 mg/ml) were
added to the cultures as indicated.
Real-Time Recordings of Bioluminescence
At 48 hr after transfection, cells were shocked for 90 min at 37C in a final
concentration of 100 nM dexamethasone. Following dexamethasone shock,
the medium was replaced with high glucose phenol red-free DMEM (GIBCO;
supplemented with 10% FBS, 10 mM HEPES [pH 7.3], nonessential amino
acids, sodium pyruvate, and 100 mM D-Luciferin). The plate was sealed with
a plastic cover and read in a temperature-controlled TECAN M200 Luminom-
eter with iTecan Software (Tecan Group, Ltd) (Vollmers et al., 2008). Lumines-
cence for each well was integrated over 5 s and read at 30 min intervals for
5 days at a temperature setting of 37C. LumiCycle data were statistically
assessed for rhythmicity using JTK_Cycle (Hughes et al., 2010) using a period
length window of 18–40 hr. Analyses used 3 days of data spanning 24–96 hr
after changing to the assay culture media. JTK_Cycle was implemented in
R (364 v2.12.1) (Hughes et al., 2010; Miyazaki et al., 2011). All scripts are
available on demand.
RNA Extraction, cDNA Synthesis, and Real-Time Quantitative PCR
Procedures were described previously (Ruan et al., 2012). qPCR data were
normalized to either u36b4 orGapdh as indicated. Primer sequences are listed
in Table S2.
Antibodies, Immunoprecipitation, and Immunoblotting
Anti-Flag (F3165) and anti-b-Actin (A5441) antibodies were from Sigma-
Aldrich. Anti-Bmal1 (A302-616A) and anti-Clock (A302-617A) were fromBethyl
Laboratories. Anti-O-GlcNAc (RL2, ab2739) and anti-OGT (ab50270) were
from Abcam. Anti-Ub (P4D1, sc-8017) and anti-Myc (9E10, sc-40) antibodies
were from Santa Cruz Biotechnology. Anti-HA antibody (12CA5) was from
Roche. Procedures for immunoprecipitation and immunoblotting assays
were described previously (Ruan et al., 2012).
Chromatin Immunoprecipitation
Procedures were described previously (Ruan et al., 2012). The 30 UTR of
Dbp was used as the negative control. A small aliquot of untreated sonicated
chromatin was reverse crosslinked and used as the total input DNA control.
Animal Studies
All procedures have been approved by the Institutional Animal Care and
Use Committee of Yale University. Male C57Bl/6 mice (10 weeks old) were
purchased from NCI/NIH. Female OGTflox/flox (5 months old) mice were gener-
ated previously (Shafi et al., 2000; Watson et al., 2010). Mice were maintained
under 12 hr light/12 hr dark cycle with free access to food andwater. Recombi-
nant adenoviruses (23 109 plaque-forming units [pfu] formales, 53 108 pfu for
females) were delivered by systemic tail-vein injection to mice. At 3–6 days
after viral infection, mice were subjected to glucose tolerance tests. Ad libitum
fed male mice were injected intraperitoneally with glucose (1.5 g/kg body
weight) at ZT1 or ZT13. Blood glucose was measured from tail-vein blood
collected at the designated times using Nova Max Glucometer. Tissues
were collected for RNA and protein isolation.Cell MStatistical Analysis
Data are presented as means ± SEM. Statistical analysis was performed
with GraphPad Prism by ANOVA using Bonferroni’s post hoc test or t test
where appropriate. Statistical analysis was accepted as significant if p value
was <0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cmet.2012.12.015.
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